0000825313-21-000027.txt : 20210504 0000825313-21-000027.hdr.sgml : 20210504 20210504080015 ACCESSION NUMBER: 0000825313-21-000027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210504 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALLIANCEBERNSTEIN HOLDING L.P. CENTRAL INDEX KEY: 0000825313 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 133434400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09818 FILM NUMBER: 21886048 BUSINESS ADDRESS: STREET 1: 1345 AVE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 2129691000 MAIL ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCE CAPITAL MANAGEMENT HOLDING LP DATE OF NAME CHANGE: 19991101 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCE CAPITAL MANAGEMENT LP DATE OF NAME CHANGE: 19961231 8-K 1 ab-20210504.htm 8-K ALLIANCEBERNSTEIN HOLDING L.P. ab-20210504
0000825313false00008253132021-05-042021-05-04


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): May 4, 2021 (May 3, 2021)

ALLIANCEBERNSTEIN HOLDING L.P.
(Exact name of registrant as specified in its charter)
Delaware001-0981813-3434400
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(I.R.S. Employer Identification Number)

1345 Avenue of the Americas, New York, NY  10105
(Address of principal executive offices)
(Zip Code)
(212) 969-1000
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading SymbolName of Each Exchange on which Registered
Units rep. assignments of beneficial ownership of limited partnership interests in AB HoldingABNYSE

















































Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

AllianceBernstein Corporation (the “Corporation”), and AllianceBernstein Holding L.P. (“AB Holding” together with the Corporation, “AB”) have entered into a retirement agreement dated May 3, 2021 (the “LC Agreement”) with Mr. Laurence E. Cranch, setting forth the terms of his retirement from the position of Chief Legal Officer of AB on December 31, 2021. Pursuant to the LC Agreement, subject to Mr. Cranch’s continued service through December 31, 2021, upon his retirement, he will be entitled to the following:

(i) salary continuation and continued medical and dental coverage for a period of twenty-six weeks following his retirement date;

(ii) incentive compensation for the 2021 performance year no less than his 2020 total year-end compensation award, which will be allocated based on the cash/deferral formula used by AB generally, with the cash portion to be paid to Mr. Cranch on the second payroll date in December 2021;

(iii) an asset management fee waiver of 100%, in accordance with AB’s policy for certain employee and employee-related accounts; and

(iv) vesting on December 31, 2021 of 121,569 of the 151,803 AB Holding units awarded to him in April 2018 relating to our headquarters relocation to Nashville, Tennessee, with delivery of the AB Holding units in respect thereof to be made on December 31, 2027 in accordance with the terms of Mr. Cranch’s deferral election.

The LC Agreement is attached hereto as Exhibit 10.01.



Item 9.01.    Financial Statements and Exhibits.

(d)    Exhibits.
    

104    Cover Page Interactive Data File (embedded within the Inline XBRL document).



            









SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ALLIANCEBERNSTEIN HOLDING L.P.
Dated: May 4, 2021By: /s/ David M. Lesser
David M. Lesser
Corporate Secretary

EX-10.01 2 lcagreement.htm EX-10.01 LC AGREEMENT Document

May 3, 2021

Laurence Cranch
Nashville, TN


Dear Laurence:

This letter (the “Agreement”) sets forth the terms of your agreement with AllianceBernstein Corporation (the "Company") and AllianceBernstein L.P. (the "Partnership").

1.    Effective as of December 31, 2021 (the "Retirement Date"), your employment as an officer of the Company and as an employee of the Partnership will terminate. You will continue to work full-time until December 31, 2021 in your current position as Chief Legal Officer, reporting to Kate Burke. You have provided written notice to the Partnership of your intent to retire from employment with the Partnership effective December 31, 2021.

2.    Payments/Benefits. (a) Until the Retirement Date and continuing for a period of 26 weeks thereafter, your base salary shall continue to be paid, through the regular payroll on regular payroll dates, at the rate of $400,000, less applicable tax withholdings and other payroll deductions. In addition, for year-end 2021, you shall be awarded total year-end compensation of no less than your 2020 total year-end incentive compensation award (the "Incentive Compensation"). The Incentive Compensation will be allocated in accordance with the cash/deferred formulas the firm uses as a whole. The deferred portion of the Incentive Compensation shall be awarded pursuant to the terms and conditions of the Incentive Compensation Award Program (''ICAP") provided you execute an ICAP Award Agreement (the "ICAP Agreement"). The cash portion of the Incentive Compensation, less applicable tax withholdings and other payroll deductions, shall be paid to you in the Company's second payroll in December of 2021. Payment and delivery, as applicable, of the Incentive Compensation shall be subject to you complying with the terms of (a) this Agreement and (b) your award agreements under ICAP. In addition, subject to you complying with the terms of this Agreement, on December 31, 2021, you shall vest in a pro rata portion of the limited partnership units in AllianceBernstein Holding L.P. (“Restricted Units”) awarded pursuant to your letter agreement dated April 24, 2018 (the “2018 Award”), which pro rata portion, based on your service through December 31, 2021, equals 121,569 Restricted Units. Pursuant to your previous election, the units in respect of such vested portion of the Restricted Units will be delivered on December 31, 2027. The Compensation Committee has determined pursuant to the 2017 Plan (as that term is hereinafter defined) (i) to accelerate vesting of the Restricted Units in accordance with the provisions for acceleration for termination without Cause set forth in the 2018 Award, and (ii) that your previous election to defer payment of the Restricted Units until December 231, 2027 (which was authorized by the Compensation Committee), complied with the requirements of the 2017 Plan. The



Company and the Partnership hereby confirm all performance requirements set forth in the 2018 Award have been satisfied.

(b)    As of the Retirement Date, your participation in and contributions to all welfare, non-qualified and qualified plans of the Partnership and its affiliates, including, but not limited to, the AllianceBernstein Partners Compensation Plan, ICAP, the 2017 Long Term Incentive Plan (the "2017 Plan"), the 2010 Long Term Incentive Plan (the "2010 Plan"), the Profit Sharing Plan for Employees of AllianceBernstein L.P. (the "Profit Sharing Plan") and the Retirement Plan for Employees of AllianceBernstein L.P. ( the "Retirement Plan"), shall cease, and your rights to a distribution, rollover, form of payment, and exercise or deferral regarding your account balances shall be determined in accordance with the terms and conditions of the respective plans and associated agreements. For the avoidance of doubt, subject to you complying with the terms of this Agreement, your termination shall be a termination without cause for purposes of your eligibility following the Retirement Date for continued vesting of your unvested benefits in accordance with the terms of your award agreements pursuant to ICAP.

(c)    Until the Retirement Date, and continuing for a period of twenty-six (26) weeks thereafter, and in accordance with applicable Company policy, as amended from time to time, the Partnership will continue in effect your medical and dental coverage, for you and your family, under its groups plans, subject to any changes, amendments or modifications that may be made by the Company to such benefits from time to time, including, but not limited to, discontinuing such coverage. As of June 30, 2022, you will be eligible to elect to continue your current level of dental coverage, and as of July 1, 2022, you will be eligible to elect your current level of medical coverage pursuant to COBRA and subject to any changes, amendments or modifications that may be made to the plan from time to time, including, but not limited, discontinuing such coverage. You acknowledge that all other benefits cease as of your last day of employment.

(d)    In accordance with Company policy, following the Retirement Date, you shall benefit from a 100% asset management fee waiver applicable to former AB Partners and Operating Committee Members (employee and employee-related accounts only), subject to any changes, amendments or modifications that may be made by the Company to this policy.

3.    Acknowledgment. You hereby acknowledge that you have carefully read this Agreement, fully understand and accept all of its provisions and signed it voluntarily of your own free will. You further acknowledge that you have been provided a full opportunity to review and consider the terms of this Agreement and have been advised by the Company to seek the advice of legal counsel of your choice. You acknowledge that you have been given a period of twenty-one (21) days to consider this Agreement. You may revoke this Agreement within seven (7) days of your signing it. For such revocation to be effective, written notice must be received by the Company no later than the seventh (7th) day after you sign this Agreement. If you revoke this Agreement, it shall be of no further force and effect.




4.    Release. (a) In consideration of the payments and benefits to be provided to you pursuant to Section 2 above, you, your heirs, executors, administrators, trustees, legal representatives, successors and assigns (hereinafter referred to collectively as "Releasors") forever release and discharge the Company and the Partnership, and their past, present and/or future parent entities, subsidiaries, divisions, affiliates and related business entities, assets, employee benefit plans or funds, successors or assigns and any and all of their past, present and/or future officers, directors, fiduciaries, partners, attorneys, employees, agents, trustees, administrators or assigns, whether acting as agents for the Company or the Partnership or in their individual capacities (hereinafter referred to collectively as "Company Entities") from any and all claims, demands, causes of action, fees and liabilities relating to your employment with the Company and Partnership or your separation of such employment of any kind whatsoever, whether known or unknown, which Releasors ever had, now have, or may have against any of the Company Entities by reason of any act, omission, transaction, practice, plan, policy, procedure, conduct, occurrence, or other matter up to and including the date of this Agreement; provided, however, that this Agreement shall not release any claims for (i) the payments and benefits set forth herein, including, but not limited to, the vesting and delivery of Restricted Units under your 2018 Award, (ii) benefits which you have as a participant in the AllianceBernstein Partners Compensation Plan, ICAP, the 2010 Plan, the 2017 Plan, the Profit Sharing Plan and the Retirement plan in accordance with the terms of such plans, or (iii) defense and indemnity under the Partnership's partnership agreement, directors' and officers' liability and fiduciary liability (or other third party liability) insurance and/or applicable law.

(b)    Without limiting the generality of the foregoing, and except as provided in Section 4(a)(i)-(iii) above, this Section 4 is intended to and shall release the Company Entities from any and all claims, whether known or unknown, which Releasors ever had, now have, or may have against the Company Entities, up to and including the date of this Agreement, arising out of your employment and/or your separation of employment with the Company or Partnership, including, but not limited to: (i) any claim under the Age Discrimination in Employment Act ("ADEA''), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Employee Retirement Income Security Act of 1974, and the Family and Medical Leave Act; (ii) any claim under the New York State Human Rights Law or the New York City Administrative Code; (iii) any other claim (whether based on federal, state or local law, statutory or decisional) relating to or arising out of your employment, the terms and conditions of such employment, the termination of such employment, and/or any of the events relating directly or indirectly to or surrounding the termination of that employment, including, but not limited to, breach of contract (express or implied), wrongful discharge, detrimental reliance, defamation, emotional distress or compensatory or punitive damages; (iv) any claim for attorneys' fees, costs, disbursements and/or the like; and (v) any claim for remuneration of any type, including, without limitation, any claim for any deferred or unvested compensation (except as specifically set forth in this Agreement).




(c)    You represent and warrant that you have not commenced, maintained, prosecuted or participated in any action, suit, charge, grievance, complaint or proceeding of any kind against the Company Entities in any court or before any administrative or legislative body or agency and/or that you are hereby withdrawing with prejudice any such complaints, charges, or actions that you may have filed against the Company Entities. You further acknowledge and agree that by virtue of the foregoing, you have waived all relief available to you (including, without limitation, monetary damages, equitable relief and reinstatement) under any of the claims and/or causes of action waived in this Section 4.

(d)    Except as provided in Section 4(a)(i)-(iii) above, you further covenant that you shall not sue, or otherwise consent to participate in any action against, and shall not assist in the instigation, commencement, maintenance, or prosecution of any action, suit, proceeding or charge against any of the Company Entities based upon any matter whatsoever (except as otherwise required by law), nor shall you testify, assist, or participate (except in response to subpoena or judicial order) in such action, suit, proceeding or charge. This Section 4 shall not prevent you from filing a charge with the relevant federal, state or local administrative agency, but you agree to waive your rights with respect to any monetary or other financial relief arising from any such administrative proceeding. You further understand that the provision of this paragraph shall not be effective with respect to, or adversely affect your rights under, the ADEA with respect to any challenge you make under the ADEA to the validity of this Agreement.

(e)    In further consideration of the payments and benefits to be provided to you pursuant to Section 2, you shall execute and deliver to the Company the release annexed hereto as Exhibit A within five (5) days after the Retirement Date.

(f)    In consideration of your agreements hereunder, the Company Entities forever release and discharge you from any and all known claims, demands, causes of action, fees and liabilities relating to your employment with the Company and the Partnership and relating to your separation therefrom, which Company Entities ever had, now have or may have against you by reason of any act, omission, transaction, practice, conduct, occurrence, or other matter up to and including the date of this Agreement; provided, however, that this release shall not include any claims related to your subsequent breach of this Agreement. Within five (5) days after the Retirement Date, the Company Entities shall deliver to you a release that is substantially similar to the release contained in this paragraph 4(f).

5.    Confidentiality. (a) As an employee of the Partnership and officer of the Company, you have had access to confidential and proprietary information of the Partnership and Company/or their respective employees (the "Confidential Information"). You acknowledge and agree that the Confidential Information is confidential and proprietary to the Partnership, the Company and their respective employees and that disclosure or use of any of the Confidential Information would be detrimental to the Partnership, the



Company and/or their clients. You agree that any and all Confidential Information shall be kept confidential and you further agree that you shall not furnish or disclose to any third party or use, directly or indirectly, for your own use or benefit or that of any other person or entity any Confidential Information of the Partnership or the Company, nor shall you attempt to access any Confidential Information. In the event that you are: (i) threatened or served with an action or motion to force disclosure of Confidential Information, or (ii) compelled to disclose Confidential Information by valid order of a court or other government entity with the authority to compel the disclosure of such information, you will notify the Partnership in writing (unless such notification would violate applicable law), and as promptly as possible (and prior to making any disclosure if possible), in order to provide the Partnership the opportunity to intervene and object to, or seek restrictions on, the disclosure of such Confidential Information. If, nevertheless, the Confidential Information is ordered to be disclosed, you will furnish only that portion of the Confidential Information as directed by the Court. You will notify the Partnership immediately upon your discovery of any unauthorized use or disclosure of Confidential Information or any other breach of this paragraph. You agree to cooperate with the Partnership and the Company at their sole expense in every reasonable way to help the Partnership and the Company regain possession of such Confidential Information and prevent its further unauthorized use.

(b)    Nothing in this Agreement prohibits you from reporting possible violations of law or regulation to any governmental agency or entity, or self-regulatory authority, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or the Financial Industry Regulatory Authority (collectively, the "Regulators"), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. You do not need the prior authorization of the Partnership or the Company to make any such reports or disclosures and you are not required to notify the Partnership or the Company that you have made such reports or disclosures. Further, nothing in this Agreement prohibits or restricts you (or your attorney) from filing a charge, responding to an inquiry, participating in an investigation, or providing testimony about this Agreement or its underlying facts and circumstances by, with, or before any Regulator. Nevertheless, you acknowledge and agree that by virtue of this Agreement, you have waived any relief available to you (including, without limitation, monetary damages, equitable relief and reinstatement) under any of the claims and/or causes of action waived in this Agreement. Therefore, you agree that you will not accept any award or settlement from any source or proceeding (including, but not limited to, any proceeding brought by any other person or by any government agency) with respect to any claim or right waived in this Agreement; provided, however, that nothing contained herein shall preclude you from receiving a monetary award from the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, 15 U.S.C.§ 78u-6.

6.    Cooperation. You, the Company and the Partnership shall cooperate in good faith to prepare internal and external communication plans regarding your termination of



employment. Any press release, Form 8K disclosure or other external statement, as well as any internal announcement regarding your termination of employment, whether written or verbal, shall be mutually agreed upon by you, the Company and Partnership.

In addition, you agree that you will reasonably assist and cooperate with the Company and the Partnership in connection with the defense or prosecution of any claim that may be made against or by the Company or the Partnership, or in connection with any ongoing future investigation or dispute involving the Company or the Partnership, including preparing for testifying in any proceeding regarding pertinent knowledge you possess. The Company and Partnership agree to provide you with reasonable advance notice of any cooperation that will be required and will schedule any required cooperation to the maximum extent possible so as not to unreasonably interfere with your scheduled business, employment and personal activities. The Company will reimburse you for (or pay directly as incurred) all reasonable expenses incurred by you in connection with such assistance and cooperation obligations under this paragraph of Section 6, including your reasonably incurred legal fees and expenses if the parties hereto agree in good faith that, in providing such cooperation, it would be reasonable for you to retain counsel independent of the counsel for the Company and/or Partnership.

7.    Partnership Property. No later than the Retirement Date, you shall return to the Partnership all documents, files and property belonging to the Partnership or the Company. For the avoidance of doubt, you may make and retain an electronic copy of your contacts list, calendar and any documents reasonably necessary in order for you to file your personal income tax returns.

8.    This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors, heirs (in your case) and assigns. Any successor of the Company or the Partnership shall assume the obligations of the Company or the Partnership, as the case may be, under this Agreement and perform any duties and responsibilities in the same manner and to the same extent that the Company or the Partnership would be required to perform if no such succession had taken place.

9.    Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be illegal, void or unenforceable, such provision shall have no effect; however, the remaining provisions shall be enforced to the maximum extent possible. Further, if a court should determine that any portion of this Agreement is overbroad or unreasonable, such provision shall be given effect to the maximum extent possible by narrowing or enforcing in part that aspect of the provision found overbroad or unreasonable.

10.    409A Compliance. The parties hereto intend that all benefits and payments to be made to you hereunder will be provided or paid to you in compliance with all applicable provisions of Section 409A of the Internal Revenue Code of 1986 as amended, and the regulations issued hereunder, and the rulings, notices, and other guidance issued by the Internal Revenue Service interpreting the same (the "Code"). If an amount is to be paid



under this Agreement in two or more installments, each installment shall be treated as a separate payment for purposes of Section 409A.

11.    Entire Agreement. You shall continue to be bound by the post-termination restraints included in this Agreement and the ICAP Agreement for a termination without cause. For the avoidance of doubt, you will be bound by the employee non-solicit but not the non-compete provision of the ICAP Agreement. Except as expressly provided herein, effective as of the Retirement Date, all prior agreements relating to your employment by the Partnership and its affiliates will terminate and be of no further effect. This Agreement contains the entire understanding with respect to the subject matter hereof, and supersedes any and all prior agreements and understandings, whether written or oral, among you, the Company, the Partnership or any affiliate thereof with respect to the subject matter hereof. This Agreement may not be altered, modified or amended except by written instrument signed by you, the Company and the Partnership. This Agreement shall be governed by New York law, without reference to principles of conflicts of law. Jurisdiction and/or venue of any question involving the validity, interpretation or enforcement of this Agreement or any of its terms, provisions or obligations, or claims or breach thereof, shall exist exclusively in a court having subject matter jurisdiction located within the City and County of New York.

12.    Counterpart Execution. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including PDF) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and to be an original signature for any and all purposes.


Sincerely,

ALLIANCEBERNSTEIN CORPORATION

By:______________________________________     
Catherine R. Spencer


ALLIANCEBERNSTEIN L.P.

By: ALLIANCEBERNSTEIN CORPORATION,
General Partner

By:______________________________________     
Catherine R. Spencer




ACCEPTED AND AGREED


______________________________________
Laurence Cranch



    


3rd day of May, 2021


































Exhibit A


In consideration for the Company's agreement to, and performance of, the terms of your Agreement dated May 3, 2021 (the “Agreement”), Employee agrees to release and discharge the Company, its subsidiaries, affiliates, successors, assigns, predecessors and any and all prior employers acquired by the Company (collectively referred to as the "Releasees") and each of the Releasees' directors, officers, agents and employees (collectively referred to as the "Releasees' Agents"), from all claims, demands, complaints, causes of action, obligations, promises, agreements, debts, expenses, fees and liabilities relating to Employee’s employment with the Company and the Partnership or Employee’s separation of such employment, that Employee has, had or may have against the Releasees or Releasees' Agents by reason of any actual or alleged act, omission, transaction, agreement, practice, policy, conduct, occurrence at any time up to and including the date Employee executes this release (the “Release”), including, but not limited to, any claims arising out of Employee's employment, the terms and conditions of Employee’s employment and the termination of Employee’s employment with Company; provided, however, that this Release shall not release any claims for (i) the payments and benefits set forth in the Agreement, including, but not limited to, the vesting and delivery of Restricted Units (as defined in the Agreement) under your letter agreement dated April 24, 2018, (ii) vested benefits which you have as a participant in the AllianceBernstein Partners Compensation Plan, ICAP, the 2010 Plan, the 2017 Plan, the Profit Sharing Plan and the Retirement plan (as those terms are defined in the Agreement) in accordance with the terms of such plan, or (iii) defense and indemnity under the Partnership's partnership agreement, directors' and officers' liability and fiduciaries’ liability (or other third party liability) insurance and/or applicable law (it being agreed that the defense and indemnity provisions under the Partnership’s partnership agreement, and defense and indemnity as it relates to Employee’s role as a fiduciary of inhouse qualified plans, and/or under applicable law, shall be available to Employee prior to and after, and shall survive, the Retirement Date, as that term is defined in the Agreement, and Employee furnishing this Release). This includes, without limitation, a release of any rights or claims Employee may have based on: the Age Discrimination in Employment Act (“ADEA”); Title VII of the Civil Rights Act of 1964; The Americans with Disabilities Act; the Family and Medical Leave Act; the Employee Retirement Income Security Act; the Worker Adjustment and Retraining Act; the New York State Human Rights Law; the Administrative Code of the City of New York; the New Jersey Law Against Discrimination; the New Jersey Conscientious Employee Protection Act; the New Jersey Family Leave Act; and the New Jersey Equal Pay Act and any other federal, state or local law, statute, rule, regulation or common law cause of action related to or arising out of Employee’s employment, the terms and conditions of Employee’s employment and the termination of Employee’s employment with Company. This Release covers both claims that Employee knows about and those he may not know about at this time. Employee agrees that he is releasing claims to the fullest extent permitted by law. This Release does not waive any rights or claims that Employee may



have which arise after Employee signs this Release or affect any benefits or rights that vested prior to Employee’s execution of this Release.

Employee promises not to file a lawsuit or initiate an arbitration asserting any claims that are released by this Release; provided, however, that nothing in this Release shall prevent Employee from exercising Employee’s right under the Older Workers Benefit Protection Act of 1990 to challenge the validity of Employee’s waiver of claims under the Age Discrimination in Employment Act set forth in the Agreement.

You hereby acknowledge that you have carefully read this Release, fully understand and accept all of its provisions and signed it voluntarily of your own free will. You further acknowledge that you have been provided a full opportunity to review and consider the terms of this Release and have been advised by the Company to seek the advice of legal counsel of your choice. You acknowledge that you have been given a period of twenty-one (21) days to consider this Release. You may revoke this Release within seven (7) days of your signing it. For such revocation to be effective, written notice must be received by the Company no later than the seventh (7th) day after you sign this Release. If you revoke this Release, the Release and the Agreement shall be of no further force and effect.
Signed before me this

__day of __    , 202__



______________________________________
Notary Public                         

______________________________________
Laurence Cranch


EX-101.SCH 3 ab-20210504.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 ab-20210504_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 ab-20210504_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 ab-20210504_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag Written Communications Written Communications City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover [Abstract] Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol EX-101.PRE 7 ab-20210504_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 ab-20210504_htm.xml IDEA: XBRL DOCUMENT 0000825313 2021-05-04 2021-05-04 0000825313 false 8-K 2021-05-04 ALLIANCEBERNSTEIN HOLDING L.P. DE 001-09818 13-3434400 1345 Avenue of the Americas New York NY 10105 212 969-1000 false false false false false Units rep. assignments of beneficial ownership of limited partnership interests in AB Holding AB NYSE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover Page
May 04, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 04, 2021
Entity Registrant Name ALLIANCEBERNSTEIN HOLDING L.P.
Entity Incorporation, State or Country Code DE
Entity File Number 001-09818
Entity Tax Identification Number 13-3434400
Entity Address, Address Line One 1345 Avenue of the Americas
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10105
City Area Code 212
Local Phone Number 969-1000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Units rep. assignments of beneficial ownership of limited partnership interests in AB Holding
Trading Symbol AB
Security Exchange Name NYSE
Entity Central Index Key 0000825313
Amendment Flag false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X9 M9K>]9!:G% MC:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z* M0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:X1+_)UW,#ECQ ,Z ME._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8 M,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0] MC.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!DZV]@A=*'UE4PX! M19W=U,5SU %ORL'C:*R$"@.4;ZH5E=>2BBTGW='K3.\?)H]:1NO<2KGW\$JV M''..?[3\ 5!+ P04 " &0*12)!Z;HJT #X 0 &@ 'AL+U]R96QS M+W=O[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E% M9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%02P,$% @ !D"D4F60>9(9 0 SP, !, !;0V]N M=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z3 M9UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A M.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G 8ED\C<+, M:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5C ME>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68* MR,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/ M^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4 " &0*12!T%- M8H$ "Q $ @ $ 9&]C4')O<',O87!P+GAM;%!+ M 0(4 Q0 ( 9 I%)8G$*O[@ "L" 1 " :\ !D M;V-0&UL4$L! A0#% M @ !D"D4AO#@KM&UL4$L! A0#% @ !D"D M4I>*NQS $P( L ( !>P\ %]R96QS+RYR96QS4$L! M A0#% @ !D"D4AE%%?4W 0 )P( \ ( !9! 'AL M+W=O7!E&UL4$L%!@ ) D /@( /<3 $! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.abglobal.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports ab-20210504.htm ab-20210504.xsd ab-20210504_cal.xml ab-20210504_def.xml ab-20210504_lab.xml ab-20210504_pre.xml lcagreement.htm http://xbrl.sec.gov/dei/2020-01-31 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ab-20210504.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "ab-20210504_cal.xml" ] }, "definitionLink": { "local": [ "ab-20210504_def.xml" ] }, "inline": { "local": [ "ab-20210504.htm" ] }, "labelLink": { "local": [ "ab-20210504_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ab-20210504_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ab-20210504.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ab", "nsuri": "http://www.abglobal.com/20210504", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ab-20210504.htm", "contextRef": "ib08256b5f52a45d38940e508734c5545_D20210504-20210504", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.abglobal.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ab-20210504.htm", "contextRef": "ib08256b5f52a45d38940e508734c5545_D20210504-20210504", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.abglobal.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0000825313-21-000027-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000825313-21-000027-xbrl.zip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end